Vir Biotechnology, Inc. (VIR)
NASDAQ: VIR · Real-Time Price · USD
9.83
+0.31 (3.26%)
At close: Apr 9, 2026, 4:00 PM EDT
9.79
-0.04 (-0.41%)
After-hours: Apr 9, 2026, 5:48 PM EDT
Vir Biotechnology Market Cap
Vir Biotechnology has a market cap or net worth of $1.57 billion as of April 9, 2026. Its market cap has increased by 59.09% in one year.
Market Cap
1.57B
Enterprise Value
1.20B
1-Year Change
59.09%
Ranking
Category
Stock Price
$9.83
Market Cap Chart
Since October 11, 2019, Vir Biotechnology's market cap has increased from $1.53B to $1.57B, an increase of 2.43%. That is a compound annual growth rate of 0.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 8, 2026 | 1.52B | 81.35% |
| Dec 31, 2025 | 838.92M | -17.01% |
| Dec 31, 2024 | 1.01B | -25.30% |
| Dec 29, 2023 | 1.35B | -59.83% |
| Dec 30, 2022 | 3.37B | -38.52% |
| Dec 31, 2021 | 5.48B | 60.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 11, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iovance Biotherapeutics | 1.65B |
| Rapport Therapeutics | 1.64B |
| Intellia Therapeutics | 1.63B |
| Immunocore Holdings | 1.61B |
| Damora Therapeutics | 1.61B |
| Oculis Holding AG | 1.61B |
| Nuvation Bio | 1.59B |
| Viridian Therapeutics | 1.57B |